Associate Director, Global Finance Commercial FP&A

AstraZenecaBoston, MA
2dHybrid

About The Position

Introduction to role: Are you ready to lead AI-powered forecasting that guides investment choices for therapies serving people with rare diseases? In this role, you will co-lead the medium-to-long range financial outlook for a high-impact therapy area, shaping the Long Term Plan and the narratives that inform senior leaders and the market. You will partner closely with R&D, Global Portfolio Analytics, and Commercial leaders across therapy areas and regions to elevate forecast accuracy, unlock intelligent automation, and build executive-ready insights. Your work will translate complex signals into clear recommendations that help deliver on ambitious targets and, ultimately, accelerate access to life-changing medicines. Do you thrive at the intersection of advanced analytics and executive decision-making? Accountabilities: Therapy Area Forecast Leadership: Co-lead medium-long range financial forecasting for Rare Disease, ensuring robust scenario planning and clear direction for investment and resource allocation. Long Term Planning: Deliver the Long Term Plan by connecting scientific progress and portfolio dynamics to commercial outcomes, partnering with R&D and Global Portfolio Analytics to align assumptions and milestones. Performance Partnership: Partner with Therapeutic Area Commercial Leads to manage financial performance, challenge assumptions, and drive target delivery across markets. Analytics and Automation: Streamline reporting and fortify analytical capabilities to support a rapidly evolving business model, deploying sophisticated solutions and automation that leverage the latest technology and AI models for speed and precision. Advanced Modeling: Prepare complex analytical and driver-based models that deepen business understanding and measurably improve forecast accuracy and cycle time. Executive Readiness: Serve as process owner for Rare Disease Quarterly Business Review, equipping the CEO and senior leaders with crisp, data-backed insights for external earnings communications. Leadership Briefings: Deliver regular, concise financial performance updates to Senior Leadership, Enterprise FP&A, and Group Finance that translate data into action. PowerBI and Anaplan Enablement: Work with Global Finance Services to define essential PowerBI dashboards for decision-making and manage the Anaplan forecasting tool to streamline planning and reporting. Forecast Governance: Drive mid-month and outturn forecast exercises; rigorously assess and challenge key revenue assumptions from therapy areas and regions to maintain credibility and agility. Center of Excellence Oversight: Manage deliverables from the Costa Rica Center of Excellence, ensuring speed, quality, and alignment to business expectations. GMMA Budget Ownership: Own the Global Marketing and Market Access financial budget and monthly cost performance; partner with business leaders to optimize spend and impact. Insightful Commentary: Consolidate monthly commentaries, explain business variances, and systematically identify risks and opportunities versus budget to inform actions. AI Innovation: Discover, evaluate, and implement AI solutions that elevate analytics and insight generation; integrate financial data with external sources to maintain high quality standards and accelerate decisions.

Requirements

  • Co-Lead together with the Director of Global Commercial FP&A, the Global Rare Disease Therapy Area medium-long range financial forecasting.
  • Deliver Long Term Plan (LTP) while leveraging key partnerships within R&D and Global Portfolio Analytics.
  • Partner with Therapeutic Area Commercial Leads to manage financial performance and target delivery.
  • Streamline and improve reporting and analytical ability to support rapidly changing business structure and environment, utilizing sophisticated solutions and automation utilizing latest technology and AI models
  • Prepare complex analytical models to support deeper business understanding and improved forecast accuracy.
  • Process owner for Rare Disease Quarterly Business Review (QBR) to prepare CEO for external earnings release.
  • Deliver regular financial performance briefings to Senior Leadership team, Enterprise Financial Planning and Analytics and AZ Group Finance.
  • Work closely with GFS to determine the essential analytical dashboards in PowerBI required to support business decision and manage Anaplan forecasting tool to streamline forecasting and reporting.
  • Drive the mid-month and Outturn forecast exercise, understanding and challenging the key assumptions used to determine the latest revenue forecast provided by the TAs and Regions.
  • Manage the key deliverables from our Center of Excellence in Costa Rica (GFS-Global Finance Services) aligned with business expectations.
  • Responsible for the GMMA (Global Marketing and Market Access) financial budget and monthly cost performance, working closely with the GMMA Business Leaders.
  • Work closely with the Global Commercial Finance TA Leaders to consolidate monthly commentaries and explanations of business variances and identify periodically risk & opportunities vs budget.
  • Discover, investigate, and implement AI solutions that directly influence business analytics and insights, enabling faster and more informed decision-making.
  • Ensure the effective use of financial data and integrate it with external sources to maintain high quality standards.

Nice To Haves

  • Track record leading global commercial FP&A forecasting cycles, including LTP, mid-month, and outturn processes.
  • Advanced proficiency with Anaplan model building and PowerBI (including DAX) to create executive-ready dashboards.
  • Experience applying AI/ML techniques in finance to automate data pipelines, enhance forecasting, and accelerate insights.
  • Proven success partnering with R&D, Portfolio Analytics, and Commercial leaders across multiple regions and therapy areas.
  • Executive-grade communication skills with experience preparing CEO-level materials and external earnings support.
  • Background in biopharma or healthcare markets; rare disease exposure a plus.
  • Experience overseeing Center of Excellence or shared services teams; Spanish language skills beneficial.
  • Professional qualifications such as MBA, CPA, or CFA valued.

Responsibilities

  • Co-Lead together with the Director of Global Commercial FP&A, the Global Rare Disease Therapy Area medium-long range financial forecasting.
  • Deliver Long Term Plan (LTP) while leveraging key partnerships within R&D and Global Portfolio Analytics.
  • Partner with Therapeutic Area Commercial Leads to manage financial performance and target delivery.
  • Streamline and improve reporting and analytical ability to support rapidly changing business structure and environment, utilizing sophisticated solutions and automation utilizing latest technology and AI models
  • Prepare complex analytical models to support deeper business understanding and improved forecast accuracy.
  • Process owner for Rare Disease Quarterly Business Review (QBR) to prepare CEO for external earnings release.
  • Deliver regular financial performance briefings to Senior Leadership team, Enterprise Financial Planning and Analytics and AZ Group Finance.
  • Work closely with GFS to determine the essential analytical dashboards in PowerBI required to support business decision and manage Anaplan forecasting tool to streamline forecasting and reporting.
  • Drive the mid-month and Outturn forecast exercise, understanding and challenging the key assumptions used to determine the latest revenue forecast provided by the TAs and Regions.
  • Manage the key deliverables from our Center of Excellence in Costa Rica (GFS-Global Finance Services) aligned with business expectations.
  • Responsible for the GMMA (Global Marketing and Market Access) financial budget and monthly cost performance, working closely with the GMMA Business Leaders.
  • Work closely with the Global Commercial Finance TA Leaders to consolidate monthly commentaries and explanations of business variances and identify periodically risk & opportunities vs budget.
  • Discover, investigate, and implement AI solutions that directly influence business analytics and insights, enabling faster and more informed decision-making.
  • Ensure the effective use of financial data and integrate it with external sources to maintain high quality standards.

Benefits

  • Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service